SYMBICORT® GAINS EUROPEAN UNION MUTUAL RECOGNITION APPROVAL FOR ASTHMA CONTROL

08-Jan-2001

AstraZeneca announced today that Symbicort®, a new and innovative treatment for asthma, has been granted approval through the Mutual Recognition Procedure (MRP) in 14 European Union (EU) states plus Norway and Iceland. This follows initial approval of Symbicort® in Sweden in August 2000. Sweden acted as the reference member state for the MRP application. In addition to these approvals, Symbicort® has been approved in Switzerland, and applications have been submitted in both Canada and Australia.

Other news from the department research and development

Most read news

More news from our other portals

Discover the latest developments in battery technology!